These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6385656

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)].
    Tobelem G, Drouet L, Caen J.
    Nouv Presse Med; 1980 Mar 15; 9(13):949-54. PubMed ID: 6987618
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S, Schulz C, Gawaz M.
    Semin Vasc Med; 2003 May 15; 3(2):147-62. PubMed ID: 15199478
    [Abstract] [Full Text] [Related]

  • 25. Early events in atherogenesis.
    Gresham GA.
    Lancet; 1975 Mar 15; 1(7907):614-5. PubMed ID: 47953
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Thromboresistance of vascular wall, atherogenesis, and humoral factors of thrombogenesis].
    Barkagan ES, Eremin GF.
    Ter Arkh; 1981 Mar 15; 53(9):71-8. PubMed ID: 7302863
    [No Abstract] [Full Text] [Related]

  • 28. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar 15; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Thrombosis and blood rheology (author's transl)].
    Niimi H, Yamamoto A.
    Iyodenshi To Seitai Kogaku; 1981 Dec 15; 19(7):498-501. PubMed ID: 7047812
    [No Abstract] [Full Text] [Related]

  • 32. Laboratory evaluation of hypercoagulability.
    Lowe GD.
    Clin Haematol; 1981 Jun 15; 10(2):407-42. PubMed ID: 6459200
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Endothelial dysfunction and atherosclerosis].
    Vanhoutte PM.
    Arch Mal Coeur Vaiss; 1997 Nov 15; 90 Spec No 6():9-19. PubMed ID: 9515109
    [Abstract] [Full Text] [Related]

  • 35. Antiplatelet drugs.
    De Meyer SF, Vanhoorelbeke K, Broos K, Salles II, Deckmyn H.
    Br J Haematol; 2008 Aug 15; 142(4):515-28. PubMed ID: 18513285
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Role of endothelial integrity in atherosclerosis.
    Schwartz SM.
    Artery; 1980 Aug 15; 8(4):305-14. PubMed ID: 7011261
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Protection by flunarizine against endothelial cell injury in vivo.
    Hladovec J, De Clerck F.
    Angiology; 1981 Jul 15; 32(7):448-62. PubMed ID: 7247070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.